title: Outcome at 6 months for 50 adolescents with major depression treated in a health maintenance organization.
abstract: OBJECTIVE
  To examine the short-term outcome of adolescents with major depressive disorder treated in a health maintenance organization (HMO) setting.
  
  
  METHODS
  Fifty consecutive adolescents meeting DSM-IV criteria for major depressive disorder at intake to an HMO clinic completed a Beck Depression Inventory (BDI), Columbia Impairment Scale, and Youth Self-Report (YSR), and a parent completed a Child Behavior Checklist at intake and 2, 4, and 6 months later.
  
  
  RESULTS
  Thirty-three percent, 40.6%, and 33% of reporting subjects showed improved mood (defined as BDI score < 9), with 78%, 64%, and 72% reporting (defined as completing a BDI) at 2, 4, and 6 months, respectively. Initial level of impairment correlated with BDI score at 2 months (p = .02) and 4 months (p = .01). Attention problems at intake as measured by the YSR correlated with BDI score at 2 months (p = .002) and 6 months (p = .003).
  
  
  CONCLUSIONS
  A minority of adolescents treated with limited, nonspecific psychotherapy and selective serotonin reuptake inhibitors have a BDI score of less than 9 at 2, 4, or 6 months. Self-report of attention problems at intake correlates with ongoing depressive symptomatology.
authors.affiliation: University of California, Davis, School of Medicine, USA. jdhamilt@ucdavis.edu
authors.forename: J D
authors.initials: JD
authors.lastname: Hamilton
authors.forename: J
authors.initials: J
authors.lastname: Bridge
mesh_terms: D000293:Adolescent; D000296:Adolescent Psychiatry; D000339:Affect; D003866:Depressive Disorder / Q000628:therapy*; D005260:Female; D006279:Health Maintenance Organizations; D006801:Humans; D008297:Male; D017063:Outcome Assessment, Health Care / Q000706:statistics & numerical data*; D011613:Psychotherapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors